Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -630,210 | -539,490 | -502,065 | -83,051 | -171,799 |
| Depreciation Amortization | 98,212 | 77,486 | 47,919 | 19,035 | 49,364 |
| Income taxes - deferred | -228,054 | -218,700 | -191,131 | -21,368 | -76,827 |
| Accounts receivable | -51,483 | -52,023 | -50,250 | -16,044 | -16,367 |
| Other Working Capital | -160,276 | -200,686 | -185,721 | -120,520 | 46,332 |
| Other Operating Activity | 743,974 | 705,786 | 663,989 | 50,494 | -50,202 |
| Operating Cash Flow | $-227,837 | $-227,627 | $-217,259 | $-171,454 | $-219,499 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -332,180 | -67,592 | 224,866 | 122,353 | -448,471 |
| PPE Investments | -148,380 | -105,189 | -70,710 | -45,204 | -227,653 |
| Net Acquisitions | -2,789 | -1,467 | -1,467 | N/A | -538,392 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | 38,244 |
| Other Investing Activity | -698 | -150 | -150 | -150 | 34,918 |
| Investing Cash Flow | $-484,047 | $-174,398 | $152,539 | $76,999 | $-1,179,598 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 787,165 | 762,436 | 23,014 | 3,521 | 951,302 |
| Other Financing Activity | -60,057 | -55,241 | -52,824 | -40,785 | -25,579 |
| Financing Cash Flow | $727,108 | $707,195 | $-29,810 | $-37,264 | $925,723 |
| Exchange Rate Effect | -3,934 | 5,139 | 3,459 | 5,132 | -5,072 |
| Beginning Cash Position | 397,040 | 397,040 | 397,040 | 397,040 | 875,486 |
| End Cash Position | 408,330 | 707,349 | 305,969 | 270,453 | 397,040 |
| Net Cash Flow | $11,290 | $310,309 | $-91,071 | $-126,587 | $-478,446 |
| Free Cash Flow | |||||
| Operating Cash Flow | -227,837 | -227,627 | -217,259 | -171,454 | -219,499 |
| Capital Expenditure | -148,380 | -105,189 | -70,710 | -45,204 | -227,653 |
| Free Cash Flow | -376,217 | -332,816 | -287,969 | -216,658 | -447,152 |